Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...